We are live on ! Find out more
MG

Marex Group Portfolio holdings

AUM $15.8B
1-Year Est. Return 31.44%
This Fund
S&P 500
This Quarter Est. Return
+25.67%
1 Year Est. Return
+31.44%
3 Year Est. Return
+143.62%
5 Year Est. Return
10 Year Est. Return
AUM
$11.5B
AUM Growth
+$6.31B
Cap. Flow
+$5.08B
Cap. Flow %
44.03%
Top 10 Hldgs %
42.58%
Holding
980
New
298
Increased
138
Reduced
168
Closed
338

Top Buys

Rank Stock Value
1
MA icon
Mastercard
MA
+$281M
2
BKNG icon
Booking.com
BKNG
+$169M
3
HUM icon
Humana
HUM
+$76.2M
4
RGTI icon
Rigetti Computing
RGTI
+$74.6M
5
MSTR icon
Strategy Inc
MSTR
+$74.1M

Top Sells

Rank Stock Value
1
IBIT icon
iShares Bitcoin Trust
IBIT
+$359M
2
BRRR icon
Coinshares Bitcoin ETF
BRRR
+$210M
3
NVDA icon
NVIDIA
NVDA
+$157M
4
AVGO icon
Broadcom
AVGO
+$123M
5
NFLX icon
Netflix
NFLX
+$114M

Sector Composition

Rank Sector Weight
1 Technology 15.53%
2 Financials 8.74%
3 Consumer Discretionary 7.67%
4 Healthcare 7.01%
5 Industrials 1.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GT icon
551
Goodyear
GT
$2.02B
$122K ﹤0.01%
11,763
+980
+9% +$10.4K
WEN icon
552
Wendy's
WEN
$1.37B
$121K ﹤0.01%
+10,568
New +$129K
HAPN
553
Happen Inc
HAPN
$2.07B
$120K ﹤0.01%
10,000
VTRS icon
554
Viatris
VTRS
$20.1B
$120K ﹤0.01%
13,449
-23,255
-63% -$197K
VYGR icon
555
Voyager Therapeutics
VYGR
$187M
$119K ﹤0.01%
38,322
SVM
556
Silvercorp Metals
SVM
$2.13B
$119K ﹤0.01%
28,200
-107,275
-79% -$416K
LION icon
557
Lionsgate Studios
LION
$3.89B
$119K ﹤0.01%
+20,482
New +$137K
OCUL icon
558
Ocular Therapeutix
OCUL
$1.89B
$115K ﹤0.01%
+12,358
New +$96.7K
NVCT icon
559
Nuvectis Pharma
NVCT
$635M
$112K ﹤0.01%
+15,000
New +$136K
BGC icon
560
BGC Group
BGC
$5.55B
$110K ﹤0.01%
+10,707
New +$98.3K
UFG
561
Uni-Fuels Holdings
UFG
$23.1M
$105K ﹤0.01%
+46,882
New +$181K
ICG
562
Intchains Group
ICG
$50.4M
$105K ﹤0.01%
58,324
+29,664
+104% +$60.1K
IQ icon
563
iQIYI
IQ
$1.17B
$101K ﹤0.01%
56,810
+37,513
+194% +$67.4K
OST icon
564
Ostin Technology Group
OST
$99.6K ﹤0.01%
+11,395
New +$1.15M
MNKD icon
565
MannKind Corp
MNKD
$1.2B
$95.2K ﹤0.01%
+25,447
New +$112K
AXG
566
Solowin Holdings
AXG
$609M
$93.3K ﹤0.01%
+29,249
New +$54.1K
HTZ icon
567
Hertz
HTZ
$603M
$92.8K ﹤0.01%
+13,580
New +$84.8K
PFAI
568
Pinnacle Food Group
PFAI
$36.5M
$89.3K ﹤0.01%
+37,733
New +$107K
NOTE
569
DELISTED
FiscalNote
NOTE
$89.1K ﹤0.01%
13,842
+9,709
+235% +$72.8K
NG icon
570
NovaGold Resources
NG
$2.6B
$86K ﹤0.01%
+21,030
New +$78.7K
OPEN icon
571
Opendoor
OPEN
$3.71B
$85.5K ﹤0.01%
165,759
+31,000
+23% +$22.4K
GOGL
572
DELISTED
Golden Ocean Group
GOGL
$82.7K ﹤0.01%
11,293
+1,293
+13% +$9.8K
BMEA icon
573
Biomea Fusion
BMEA
$91.1M
$81K ﹤0.01%
45,000
-40,000
-47% -$77.1K
BBBY
574
Bed Bath & Beyond
BBBY
$471M
$79.5K ﹤0.01%
12,709
-82,728
-87% -$401K
COMP icon
575
Compass
COMP
$8.05B
$75.9K ﹤0.01%
+12,085
New +$82.8K

Similar funds

Marex Group's Q2 2025 Portfolio in Review

As of Q2 2025, Marex Group held 980 positions worth $11.5B, up 121% from $5.22B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Marex Group deployed $5.08B of net new capital in Q2 2025, opening 298 new positions and adding to 138 existing holdings. Its largest new stake was Humana: 305,720 shares worth $74.7M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 31% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was iShares Bitcoin Trust, an estimated $359M trimmed.

  • Marex Group's largest Q2 2025 buy was Humana: 305,720 shares worth $74.7M.
  • Marex Group added most to Mastercard in Q2 2025, an estimated $281M increase.
  • Marex Group's biggest Q2 2025 reduction was iShares Bitcoin Trust, cutting an estimated $359M.
  • Marex Group fully exited Coinshares Bitcoin ETF in Q2 2025, selling an estimated $210M.
  • Marex Group's ten largest holdings make up 43% of its $11.5B portfolio in Q2 2025.
  • Marex Group opened 298 new positions and closed 338 in Q2 2025.
  • Marex Group's portfolio value rose 121% quarter-over-quarter to $11.5B.

Based on Marex Group's 13F filing for Q2 2025, filed 19 Aug 2025.